Reported Tuberculosis in the United States, 2020

Return to Main Menu

Table 16. National Tuberculosis Genotyping Surveillance Coverage:1 United States, 2004–2020

See Surveillance Slide #66.

Table 16. National Tuberculosis Genotyping Surveillance Coverage: United States, 2004-2019
Year Reported TB Cases Reported Culture-Positive Cases Cases with Genotype Results Genotype Surveillance Coverage
No. No. No. (%)
2004 14,502 11,330 5,954 (52.6)
2005 14,063 10,955 7,497 (68.4)
2006 13,730 10,747 7,528 (70.0)
2007 13,288 10,434 8,425 (80.7)
2008 12,893 10,024 8,176 (81.6)
2009 11,499 8,866 7,701 (86.9)
2010 11,076 8,391 7,684 (91.6)
2011 10,480 8,063 7,597 (94.2)
2012 9,925 7,616 7,224 (94.9)
2013 9,545 7,355 7,048 (95.8)
2014 9,383 7,217 6,973 (96.6)
2015 9,536 7,409 7,199 (97.2)
2016 9,242 7,171 6,985 (97.4)
2017 9,071 7,130 6,945 (97.4)
2018 9,006 7,102 6,954 (97.9)
2019 8,904 7,100 6,966 (98.1)
2020 7,174 5,691 5,551 (97.5)

Show More

1Genotype surveillance coverage is defined as the percentage of all culture positive tuberculosis (TB) cases for which there was a genotyped isolate.

Note: This table reflects genotyping surveillance coverage for the 50 states and the District of Columbia; for genotyping surveillance coverage of the U.S.-affiliated areas, please see Table 17.